The mortality rate for ovary malignant neoplasms in Brazil is projected to increase progressively from 4.28 thousand female deaths in 2024 to 4.57 thousand in 2028. Comparing the forecast with historical data from 2023, where values stood at 4.21 thousand, the trend reflects a consistent year-over-year growth, showcasing a steady escalation in mortality rates by approximately 1.9% annually. The compound annual growth rate (CAGR) over the 5-year period will be approximately 1.7%.
Future trends to watch include advancements in medical interventions and early diagnosis, which could potentially mitigate the forecasted increases. Additionally, public health initiatives focusing on awareness and prevention may play a critical role in shaping these outcomes and altering projected mortality trends.
